Dopamine and somatostatin inhibit release of pituitary prolactin and growth hormone ( G H ) respectively. In some species this inhibition is accompanied by lowering of cyclic A M P levels. Thus, in rat anterior pituitary membranes, dopamine can inhibit vasoactive intestinal peptidcstimulated adenylate cyclase activity 11 I and somatostatin can inhibit GH-releasing hormone (GHRH)-stimulated adenylate cyclase 121. Both factors can inhibit forskolin-stimulated rat adenylate cyclase.
In ovinc anterior pituitary cells. however. dopamine and somatostatin do not inhibit cyclic A M P accumulation. Thus, Law ei a/. 131 showed that although somatostatin can inhibit GHRH-stimulated G H secretion in both rat and ovine anterior pituitary cells, it lowered cyclic A M P levcls only in the rat cells. Similarly, Ray et uI. [4] found that dopamine and somatostatin could inhibit forskolin-stimulated GH and prolactin secretion, but not cyclic A M P accumulation in ovinc pituitary cells. It is unlikely that heterogeneity o f pituitary cells contributes t o these observations, since similar results were obtained using an enriched preparation of somatotrophs 151.
T h e different responses o f ovine and rat pituitary cells could lie at the level of the inhibitory G proteins that are known t o link hormone-receptor complexes t o intracellular effector systems. We therefore investigated ( ( I ) whether the Ahhreviations used: GH. growth hormone: GHRH. GH-releasing hormone.
ovine pituitary cclls have ii decrcascd content o f the inhihitory G-protein G, and ( h ) whether the adenylate cyclase activities of ovine and rat pituitary membranes respond similarly.
Ovine and rat anterior pituitary membranes were prepared as described by McDonald et rrl. 161. Adenylate cyclase activity was measured by a specific radioimniunoassay for cyclic A M P 171. T h e pertussis toxin-catalysed ADP ribosylation reaction was carried out a s described by Zysk ei 
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forskolin-stimulated ovine adenylate cyclase activity (I'<O.OI) in the presence of less than 1 mwfree Mg?+ (Table I) .
To assess whether the D-2 receptor is functionally coupled to this G, protein, the dopamine agonist bromocryptine was employed. Bromocryptine did significantly inhibit ( I ) < 0.0 I ) forskolin-stimulated adenylate cyclase activity in rat anterior ituitary membranes (Table 1 ) as demonstrated previously P 1 1 I. Bromocryptine did not. however, inhibit forskolinstimulated adenylate cyclase activity in ovine pituitary membranes (Table 1 ) . These studies suggest that in ovine anterior pituitary cells G, is present and is functionally coupled to adenylate cyclase (since GTP can inhibit adenylate cyclase), but that the coupling between G, and the D-2 receptor is defective. This could provide an explanation for the failure of dopamine to inhibit cyclic AMP accumulation in ovine pituitary cells under most circumstances (though dopamine does lower cyclic AMP raised by isobutylmethylxanthine in such cells 11 21) and presumably reflects a difference between ovine and rat pituitary cells. It seems likely that a similar situation applies to the case o f somatostatin. The mechanisms responsible for mediating the actions o f dopamine and somatostatin on ovine pituitary cells remain undefined, though changes in intracellular ICa? + I arc likely, and possibly effects on other cell-signalling systems.
We thank S.E.R.C. for a research studentship t o R.S.B. One of the initial findings of elevating cyclic AMP concentrations was the stimulation of glycogen phosphorylase. In this study thc effect of elevating cyclic AMP, by different ANNE-MARIE L. SEYMOUR* methods, on the phosphorylase a activity (expressed as a percentage of total phosphorylasc activity) has been investigated. Two different methods of enhancing adenylate cyclase activity were compared, as were inhibitors of two isoenzymcs of phosphodiesterases (phosphodiesterase 111 and phosphodiesterase IV).
The effects of adenylate cyclase activation by either isoprenaline or forskolin on cyclic AMP content and the phosphorylase activation ratio in A,,, cells arc shown in Table 1 . It can be seen from this Table that while the maximum dose of forskolin increased the cyclic AMP concentration t o a greater extent than any o f thc doses of isoprcnaline, it produced a smaller degree of phosphorylase activation. It can also be seen that the phosphorylase activation ratio. generated by forskolin, for a givcn level o f cyclic AMP increases with time, whereas for isoprcnaline. the ratio decreases with time. 
